“…Symptomatic fractures since lupus diagnosis occur in 6 -12.5% of patients (7,13,42,44), and the hip/femur, vertebra, rib, foot, ankle, and arm are the most frequent sites of fractures (7,42,44). Age (7,13,42), postmenopausal status (7), smoking (17), disease duration (44), renal insufficiency (17), Raynaud's syndrome (17), lupus anticoagulant (17), and reduced BMD (13) are reported as risk factors for symptomatic fractures in SLE patients. In addition, GC treatment (both cumulative and highest dose [7,45]) is a predictor of osteoporotic fractures, and longer use of GCs is associated with time from lupus diagnosis to fracture (42).…”